SELLAS Life Sciences Group (SLS) Institutional Ownership $1.19 -0.03 (-2.46%) (As of 10/9/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for SELLAS Life Sciences Group (NASDAQ:SLS)CurrentInstitutional OwnershipPercentage17.38%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$5.96MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$20.69K Get SLS Insider Trade Alerts Want to know when executives and insiders are buying or selling SELLAS Life Sciences Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SLS Institutional Buying and Selling by Quarter Ad Behind the Markets“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Take these 4 steps to protect your retirement here >>> SELLAS Life Sciences Group Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/9/2024Renaissance Technologies LLC32,446$39K0.0%N/A0.056% 5/20/2024Virtu Financial LLC39,429$40K0.0%-34.2%0.068% 5/14/2024Anson Funds Management LP4,832,368$4.88M0.3%N/A8.366% 4/26/2024Opus Capital Group LLC200,600$203K0.0%+48.6%0.356% 2/13/2024Armistice Capital LLC820,000$869K0.0%N/A2.558% 1/31/2024Opus Capital Group LLC135,000$143K0.0%+291.3%0.421% Get the Latest News and Ratings for SLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SELLAS Life Sciences Group and its competitors with MarketBeat's FREE daily newsletter. 9/12/2023Prosperity Financial Group Inc.29,800$47K0.0%N/A0.105% 5/11/2023Highbridge Capital Management LLC1,805,054$2.58M0.0%N/A6.367% 1/18/2023Opus Capital Group LLC19,672$46K0.0%N/A0.096% 11/15/2022Empery Asset Management LP308,466$623K3.7%-66.8%1.501% 2/14/2022GSA Capital Partners LLP10,447$58K0.0%N/A0.066% 2/11/2022Equitable Holdings Inc.102,000$564K0.0%+2.0%0.642% 11/12/2021Jump Financial LLC14,627$134K0.0%N/A0.092% 11/12/2021Equitable Holdings Inc.100,000$916K0.0%+6.0%0.630% 11/12/2021Geode Capital Management LLC133,801$1.23M0.0%+32.0%0.843% 8/25/2021Marshall Wace LLP84,544$938K0.0%+63.0%0.533% 8/17/2021Price T Rowe Associates Inc. MD15,500$172K0.0%-42.8%0.103% 8/16/2021Morgan Stanley15,499$172K0.0%+297.4%0.103% 8/16/2021Pinz Capital Management LP10,700$119K0.0%-18.3%0.071% 8/16/2021State Street Corp37,468$416K0.0%N/A0.248% 8/16/2021Marshall Wace LLP84,544$938K0.0%+63.0%0.560% 8/13/2021Northern Trust Corp24,605$273K0.0%+35.9%0.163% 8/13/2021Geode Capital Management LLC101,337$1.12M0.0%+6.8%0.672% 8/13/2021Vanguard Group Inc.618,534$6.87M0.0%+31.6%4.100% 8/12/2021Dimensional Fund Advisors LP20,320$226K0.0%+31.9%0.135% 8/12/2021Bank of Montreal Can109,282$1.43M0.0%N/A0.724% 8/11/2021Bank of New York Mellon Corp20,332$226K0.0%+30.3%0.135% (Data available from 1/1/2016 forward) SLS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SLS shares? During the previous two years, the following institutional investors and hedge funds held shares of SELLAS Life Sciences Group shares: Anson Funds Management LP ($4.88M), Highbridge Capital Management LLC ($2.58M), Armistice Capital LLC ($869K), Empery Asset Management LP ($623K), Opus Capital Group LLC ($203K), Prosperity Financial Group Inc. ($47K), and Virtu Financial LLC ($40K).Learn more on SLS's institutional investors. What percentage of SELLAS Life Sciences Group stock is owned by institutional investors? 17.38% of SELLAS Life Sciences Group stock is owned by institutional investors. Learn more on SLS's institutional investor holdings. Which institutional investors have been buying SELLAS Life Sciences Group stock? The following institutional investors have purchased SELLAS Life Sciences Group stock in the last 24 months: Anson Funds Management LP ($4.83M), Highbridge Capital Management LLC ($1.81M), Armistice Capital LLC ($820K), Opus Capital Group LLC ($185.77K), Renaissance Technologies LLC ($32.45K), and Prosperity Financial Group Inc. ($29.80K). How much institutional buying is happening at SELLAS Life Sciences Group? Institutional investors have bought a total of 7,705,440 shares in the last 24 months. This purchase volume represents approximately $8.64M in transactions. Which SELLAS Life Sciences Group major shareholders have been selling company stock? The following institutional investors have sold SELLAS Life Sciences Group stock in the last 24 months: Empery Asset Management LP ($619.52K), and Virtu Financial LLC ($20.49K). How much institutional selling is happening at SELLAS Life Sciences Group? Institutional investors have sold a total of 640,003 shares in the last 24 months. This volume of shares sold represents approximately $1.27M in transactions. Related Companies: Corvus Pharmaceuticals Major Shareholders Voyager Therapeutics Major Shareholders Galecto Major Shareholders Inozyme Pharma Major Shareholders Korro Bio Major Shareholders Alto Neuroscience Major Shareholders Esperion Therapeutics Major Shareholders Heron Therapeutics Major Shareholders Kamada Major Shareholders Genfit Major Shareholders This page (NASDAQ:SLS) was last updated on 10/9/2024 by MarketBeat.com Staff From Our Partners$20 = Ounce of Gold?I've discovered a way to get exposure to MORE than an ounce of gold... for under $20. It's not bullion. It'...Monument Traders Alliance | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredBigger Than Nvidia?Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the n...InvestorPlace | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredAI Expert Reveals New PickYour Financial Planner Won't Tell You About This Investment Strategy Silicon Valley insider Jeff Brown has ...Brownstone Research | SponsoredClaim Your FREE "AI Income Playbook" Now!Income expert Marc Lichtenfeld has a special gift reserved just for you... It's his brand-new "AI Income Pl...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SELLAS Life Sciences Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SELLAS Life Sciences Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.